Reddit attention helps spur cannabis stocks
CNBC’s Frank Holland reports on the action in Cannabis stocks as Reddit’s WallStreetBets crowds seems to spur the move higher. For access to live and exclusive video from CNBC subscribe…
Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC
It’s a medical marijuana company helping over 80,000 patients and you may have never heard of it. Jim Cramer looks into Trulieve and what it can tell us about the…
Green Growth mulls takeover bid for Canadian cannabis company Aphria
CNBC’s Aditi Roy discusses Green Growth’s takeover bid of Canadian cannabis company Aphria following the country’s legalization of marijuana this year. Subscribe to CNBC: About CNBC: From ‘Wall Street’ to…
ETF Spotlight: Aurora cannabis hit by pandemic-related restrictions
CNBC’s Morgan Brennan takes a look at cannabis-focused ETFs and the dip in Aurora shares. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Subscribe to…
How illegal dispensaries are a threat to the legal cannabis industry
The booming business of cannabis is what many investors are calling the new gold rush. But with those potential riches comes this reality: there’s a much bigger boom in the…
U.S. vs. Canadian cannabis stocks: Key distinctions
Tim Seymour, who runs the Amplify Seymour Cannabis ETF (CNBS), explains the performance discrepancy between U.S. and Canadian pot stocks around U.S. elections. For access to live and exclusive video…
Canopy Growth CEO on cannabis sell-off
Bruce Linton, Canopy Growth CEO, discusses the volatile moves in cannabis stocks just a week after Canada legalized recreational marijuana use.
Hexo needs strategic options to compete in cannabis industry: Activist investor
Activist investor and Riposte Managing Partner Khaled Beydoun explains why he believes Canadian cannabis company Hexo can go higher.
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…
US Officials could be ready to crack down on cannabis craze
Are US border officials cracking down on the cannabis industry? Pot stocks get smoked. With CNBC’s Aditi Roy and Scott Wapner, and the Fast Money traders, Pete Najarian, Tim Seymour,…